DEINOVE (Alternext Paris: ALDEI), a biotech company that discovers, develops and produces high-value compounds from rare bacteria, notably...
Completion of the contribution in kind of DEINOBIOTICS’ shares to DEINOVE which now holds 100% of its subsidiary Consequential DEINOVE’s...
19.06.2017 to 22.06.2017
Dominique LE BELLER, CEO of the DEINOBIOTICS subsidiary, to participate to the congress alongwith the "Nutrition Santé Longévité" French...
09.05.2017 to 11.05.2017